Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upgrade to Pro+ | Saudi Arabia | Consumer Cyclicals | Media & Publishing | 17.9% | SAR 17.46B | 34.9x | 0.07 | SAR 54.60 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.9% Upside | Upgrade to Pro+ | |
Upgrade to Pro+ | Saudi Arabia | 10.2% | SAR 128.10M | 14.4x | 0.44 | SAR 61.80 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Upgrade to Pro+ | Saudi Arabia | 9.9% | SAR 343.20M | 11.4x | 0.19 | SAR 45 | 4.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Upgrade to Pro+ | Saudi Arabia | Healthcare | Healthcare Equipment & Supplies | 9.4% | SAR 831.18M | 23.9x | 0.39 | SAR 42.20 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | Saudi Arabia | Consumer Non-Cyclicals | Food & Tobacco | 6.8% | SAR 2.51B | 18.9x | 0.4 | SAR 390 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -25.4% Downside | Upgrade to Pro+ | |
Upgrade to Pro+ | Saudi Arabia | Healthcare | Pharmaceuticals | -0.4% | SAR 387.10M | 15.6x | 0.15 | SAR 110.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Upgrade to Pro+ | Saudi Arabia | Healthcare | Healthcare Equipment & Supplies | -3% | SAR 312.90M | 10.8x | 0.5 | SAR 89.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |